Omnipharm Limited / SAS Merial, Court of Appeal Paris (Cour d'appel Paris), 17 February 2012
The Paris Court of Appeal clarified the interest of a potential competitor to seek the revocation of a patent. It was particularly unclear whether any competitor, current or potential, could have a legitimate interest in the form of a “clear the path” approach. However, in this case the Court held that Omnipharm had no legitimate…